PDS Biotechnology
PDSB
32 hedge funds and large institutions have $14.3M invested in PDS Biotechnology in 2021 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 9 closing their positions.
107% more capital invested
Capital invested by funds: $6.92M → $14.3M (+$7.39M)
29% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 7
22% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 9
7% more funds holding
Funds holding: 30 → 32 (+2)
0.01% less ownership
Funds ownership: 14.14% → 14.13% (-0.01%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IC
Ikarian Capital
Dallas,
Texas
|
+$1.54M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$591K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$314K |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$178K |
| 5 |
BFM
Boothbay Fund Management
New York
|
+$173K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$822K |
| 2 |
Renaissance Technologies
New York
|
-$648K |
| 3 |
BlackRock
New York
|
-$248K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$224K |
| 5 |
GAM
Gotham Asset Management
New York
|
-$219K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Osaic Holdings
Scottsdale,
Arizona
| $7K | +$2.82K | +700 | +86% |
|
|
TCWM
27
Total Clarity Wealth Management
St. Charles,
Illinois
| $7K | +$6.04K | +1,500 | New |
|
|
TC
28
Truvestments Capital
Sarasota,
Florida
| $3K | +$2.64K | +655 | New |
|
|
AWA
29
Arkadios Wealth Advisors
Atlanta,
Georgia
| $2K | +$2.01K | +500 | New |
|
30
Wells Fargo
San Francisco,
California
| $1K | -$4 | -1 | -0.8% |
|
|
31
Federated Hermes
Pittsburgh,
Pennsylvania
| – | -$822K | -384,000 | Closed |
|
|
32
UBS Group
Zurich,
Switzerland
| – | -$224K | -104,890 | Closed |
|
|
GAM
33
Gotham Asset Management
New York
| – | -$219K | -15,429 | Closed |
|
|
IGGA
34
Iron Gate Global Advisors
Nsl,
Utah
| – | -$28K | -13,192 | Closed |
|
|
NS
35
Newman & Schimel
Deerfield,
Illinois
| – | -$25K | -11,500 | Closed |
|
36
Two Sigma Investments
New York
| – | -$24K | -11,290 | Closed |
|
|
OCM
37
Orion Capital Management
Coronado,
California
| – | -$17K | -7,870 | Closed |
|
|
BCM
38
Bourgeon Capital Management
Darien,
Connecticut
| – | -$5K | -2,300 | Closed |
|
39
Bank of America
Charlotte,
North Carolina
| – | +$366 | +91 | +607% |
|
PDSB Hedge Fund Activity: Q1 2021 in Review
32 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in PDS Biotechnology (PDSB) for Q1 2021, worth a combined $14.3M — up 107% from $6.92M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new PDSB positions and 9 closed out — a net gain of 2 holders — while 9 added to existing stakes and 7 trimmed.
The largest buyer was Ikarian Capital, opening a new position worth an estimated $1.54M. The largest seller was Federated Hermes, exiting entirely with an estimated $822K sold.
- 32 institutional investors held PDS Biotechnology (PDSB) as of Q1 2021, up from 30 in Q4 2020.
- Funds reported $14.3M of PDS Biotechnology stock for Q1 2021, up 107% quarter-over-quarter.
- 11 funds opened new PDS Biotechnology positions in Q1 2021 and 9 closed out, a net change of +2 holders.
- The largest PDS Biotechnology buyer in Q1 2021 was Ikarian Capital, an estimated $1.54M added.
- The largest PDS Biotechnology seller in Q1 2021 was Federated Hermes, an estimated $822K sold.
Based on aggregated 13F filings for Q1 2021.